Metagenomi (MGX) Institutional Ownership → Was the Great Financial Crisis fun? (From Brooks Enterprises) (Ad) Free MGX Stock Alerts $6.55 -0.01 (-0.15%) (As of 06/5/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Metagenomi (NASDAQ:MGX)Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$47.35MNumber ofInstitutional Sellers(last 12 months)0 Get MGX Insider Trade Alerts Want to know when executives and insiders are buying or selling Metagenomi stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MGX Institutional Buying and Selling by Quarter Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. Metagenomi Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/24/2024 Farallon Capital Management LLC1,343,201$14.17M0.1%N/A3.586% 5/17/2024 RA Capital Management L.P.1,744,415$18.40M0.2%N/A4.657% 5/17/2024 Artal Group S.A.300,000$3.17M0.1%N/A0.801% 5/15/2024 Hhlr Advisors LTD.777,768$8.21M0.2%N/A2.076% 5/15/2024 Altitude Crest Partners Inc.133,333$1.41M0.6%N/A0.356% 5/10/2024 Vanguard Group Inc.179,547$1.89M0.0%N/A0.479% 5/10/2024 Resolute Advisors LLC10,000$106K0.0%N/A0.027% (Data available from 1/1/2016 forward) MGX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MGX shares? During the previous two years, the following institutional investors and hedge funds held shares of Metagenomi shares: RA Capital Management L.P. ($18.40M), Farallon Capital Management LLC ($14.17M), Hhlr Advisors LTD. ($8.21M), Artal Group S.A. ($3.17M), Vanguard Group Inc. ($1.89M), and Altitude Crest Partners Inc. ($1.41M), and Resolute Advisors LLC ($106K).Learn more on MGX's institutional investors. Which institutional investors have been buying Metagenomi stock? The following institutional investors have purchased Metagenomi stock in the last 24 months: RA Capital Management L.P. ($1.74M), Farallon Capital Management LLC ($1.34M), Hhlr Advisors LTD. ($777.77K), Artal Group S.A. ($300K), Vanguard Group Inc. ($179.55K), Altitude Crest Partners Inc. ($133.33K), and Resolute Advisors LLC ($10K). How much institutional buying is happening at Metagenomi? Institutional investors have bought a total of 4,488,264 shares in the last 24 months. This purchase volume represents approximately $47.35M in transactions. Related Companies: Immatics Institutional Ownership Mesoblast Institutional Ownership Relay Therapeutics Institutional Ownership Prime Medicine Institutional Ownership Scholar Rock Institutional Ownership CARGO Therapeutics Institutional Ownership REGENXBIO Institutional Ownership Valneva Institutional Ownership iTeos Therapeutics Institutional Ownership HilleVax Institutional Ownership This page (NASDAQ:MGX) was last updated on 6/6/2024 by MarketBeat.com Staff From Our PartnersMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | SponsoredBUY ALERT: Tiny tech play partners with US governmentThe Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. ...Stansberry Research | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored[Webinar] Understanding Covered CallsDiscover the details of this option-selling strategy.OIC | Sponsored"The Biggest Drug Ever" Is ComingUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Phar...Behind the Markets | SponsoredBitcoin’s Biggest Year Yet2024 is set to be a historic year for Bitcoin. It’s all thanks to three major catalysts that I reveal in my...Paradigm Press | SponsoredClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an eff...Crypto Swap Profits | SponsoredAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metagenomi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metagenomi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.